Characteristics of endometrial cancer progressed to extrauterine lesions following fertility preserving medroxyprogesterone acetate therapy for young endometrial cancer patients
Only 2.2% of all patients developed ELs post-MPA treatment, but some cases were fatal. It is essential to conduct imaging tests and screen for tumor markers during and after MPA treatment regularly and also when cancer progression is suspected.
Authors
- Miho Kawaida (ORCID: https://orcid.org/0000-0003-0353-4246)
- Kouji Banno (ORCID: https://orcid.org/0000-0003-2610-2833)
- Wataru Yamagami (ORCID: https://orcid.org/0000-0003-3925-6057)
- Shoko Kitazawa (ORCID: https://orcid.org/0000-0002-4934-6622)
- Tatsuyuki Chiyoda (ORCID: https://orcid.org/0000-0002-8214-2242)
- Hiroshi Nishio (ORCID: https://orcid.org/0000-0002-4938-416X)
- Nobuyuki Susumu (ORCID: https://orcid.org/0000-0002-3537-7161)
- Kensuke Sakai (ORCID: https://orcid.org/0000-0002-1406-086X)
Institutions
- Keio University (JP)
- Hiroshima University Hospital (JP)
- International University of Health and Welfare (JP)
Publication Details
- Journal
- Journal of Gynecologic Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.3802/jgo.2025.36.e104
- Citations
- 1
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.06
Funders
- Keio University